ARTICLE | Clinical News
VSV-EBOV: Phase I started
October 20, 2014 7:00 AM UTC
NewLink began a U.S. Phase I trial to evaluate VSV-EBOV. NewLink's BioProtection Systems Corp. subsidiary has exclusive, worldwide rights to develop and commercialize the vaccine from the Public Healt...